arginine vasopressin has been researched along with timolol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bannan, LT; Beevers, DG; Potter, JF | 1 |
Matsuda, T; Mori, M; Tsushima, H | 1 |
1 review(s) available for arginine vasopressin and timolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine vasopressin and timolol
Article | Year |
---|---|
The effect of a non-selective lipophilic beta-blocker on the blood pressure and noradrenaline, vasopressin, cortisol and renin release during alcohol withdrawal.
Topics: Adult; Arginine Vasopressin; Blood Pressure; Chlormethiazole; Clinical Trials as Topic; Double-Blind Method; Ethanol; Humans; Hydrocortisone; Male; Middle Aged; Norepinephrine; Placebos; Renin; Substance Withdrawal Syndrome; Timolol | 1984 |
3 other study(ies) available for arginine vasopressin and timolol
Article | Year |
---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Microinjections of angiotensin II into the supraoptic and paraventricular nuclei produce potent antidiureses by vasopressin release mediated through adrenergic and angiotensin receptors.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Diuresis; Dose-Response Relationship, Drug; Injections, Intra-Arterial; Injections, Intraventricular; Male; Microinjections; Paraventricular Hypothalamic Nucleus; Phenoxybenzamine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Angiotensin; Supraoptic Nucleus; Timolol; Vasoconstriction; Vasopressins | 1994 |